SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (9262)7/14/2005 12:29:30 PM
From: Galirayo  Read Replies (1) of 23958
 
Bernard .. May I ask a question about VPHM ??

When these Notes are converted to Common are they able to be sold or are they Restricted?

TIA,
Ray

bizjournals.com
ViroPharma will convert debt into common stock
Wednesday July 6, 10:31 am ET

ViroPharma Inc. said Wednesday it plans to exercise its right to automatically convert the remaining $15.35 million principal amount of its convertible senior secured notes, due October 2009, into 6.14 million shares of common stock.
ADVERTISEMENT


The Exton, Pa., biopharmaceutical company issued $75 million of convertible senior notes in connection with its acquisition of Vancocin, a treatment of antibiotic-associated infection of the gut known as pseudomembranous colitis, from Eli Lilly & Co.

The auto-conversion will occur on July 12.

"With this final auto conversion, we will have eliminated the entirety of the 2009 convertible senior notes from our balance sheet," said Vincent Milano, the chief financial officer of ViroPharma (NASDAQ: VPHM - News).

Milano said the company has reduced its overall debt by 57 percent during the past two months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext